Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 668

Sort by

Sort Order Select

Journal Articles

Single-cell panleukemia signatures of HSPC-like blasts predict drug response and clinical outcome

Blood (2025) 145 (23): 2685–2700.

https://doi.org/10.1182/blood.2024027270

Published: 2025

Includes: Supplemental data

Journal Articles

Targeting caseinolytic mitochondrial matrix peptidase, a novel contributor to the pathobiology of high-risk multiple myeloma

Blood (2025) 145 (22): 2614–2629.

https://doi.org/10.1182/blood.2024024781

Published: 2025

Includes: Supplemental data

Journal Articles

N-homocysteinylation of β-arrestins biases GPCR signaling and promotes platelet activation

Blood (2025) 145 (20): 2374–2389.

https://doi.org/10.1182/blood.2024025593

Published: 2025

Includes: Supplemental data

Journal Articles

Targeting Enterobacter cloacae attenuates osteolysis by reducing ammonium in multiple myeloma

Blood (2025) 145 (17): 1876–1889.

https://doi.org/10.1182/blood.2024025694

Published: 2025

Includes: Supplemental data

Journal Articles

Venetoclax, Azacitidine, Combined with Low-Dose Cytarabine in Older Newly Diagnosed Acute Myeloid Leukemia：the Result of a Prospective, Multicenter, Open, Randomized Controlled Trials

Blood (2024) 144 (Supplement 1): 2902.

https://doi.org/10.1182/blood-2024-206513

Published: 2024

Journal Articles

A Prospective Clinical Study of Venetoclax Plus Azacitidine for the Maintenance Treatment of Post-Remission Acute Myeloid Leukemia

Weiming Li, Fang Cheng, Jing Zou, Yuanyan Tang, Haiyan Wang, Jie Tan, Qihuan Liu, Hongbo Ren, Meifang Su, Hongxiang Wang, Zhuangzhi Yang, Lulu Zhang, Renying Ge, Jing He, Chuancai Liu, Jun Qin, Jing Zheng, Zhe Zhao

Blood (2024) 144 (Supplement 1): 2888.

https://doi.org/10.1182/blood-2024-204414

Published: 2024

Journal Articles

A Phase 1 Dose Escalation and Expansion Trial of Third-Generation CD19-Directed CAR T-Cells Incorporating CD28 and Toll-like Receptor 2 (TLR2) Co-Stimulation for Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas (ENABLE-1)

Blood (2024) 144 (Supplement 1): 2067.

https://doi.org/10.1182/blood-2024-201138

Published: 2024

Journal Articles

Elucidation of Molecular Mechanisms of Iberdomide and Mezigdomide Resistance in Cell Line Models of Multiple Myeloma

Wei Tan, Minghao Dang, Upasana Ray, Luz Yurany Moreno Rueda, Maria Jose Acevedo-Calado, Hua Wang, Jun Wei, Li Qin, Isere Kuiatse, Robert Z. Orlowski

Blood (2024) 144 (Supplement 1): 4640.

https://doi.org/10.1182/blood-2024-207917

Published: 2024

Journal Articles

Single-Cell Multi-Omic Profiling of Patients with BCMA-Targeted Therapy Identifies Molecular and Cellular Factors Associated with Responsiveness and Treatment Effects

Minghao Dang, Hans C. Lee, Hima Bansal, Maria Acevedo-Calado, Li Qin, Wei Tan, Luz Yurany Moreno Rueda, David Berrios, Krina K. Patel, Pei Lin, Sheeba K. Thomas, Donna M. Weber, Linghua Wang, Robert Z. Orlowski

Blood (2024) 144 (Supplement 1): 767.

https://doi.org/10.1182/blood-2024-204313

Published: 2024

Journal Articles

Factors Associated with Progression to Overt Acute Myeloid Leukemia in NPM1 -Mutated Myeloid Neoplasms with Less Than 10% Blasts

Jingye Gong, Tiejun Qin, Zefeng Xu, Bing Li, Shiqiang Qu, Lijuan Pan, Qingyan Gao, Meng Jiao, Robert Peter Gale, Zhijian Xiao

Blood (2024) 144 (Supplement 1): 2871.

https://doi.org/10.1182/blood-2024-212110

Published: 2024

Journal Articles

Genetic Abnormalities Associated with Outcomes in Unfit Patients with Acute Myeloid Leukemia Receiving Less Intensive Therapy in the Real World

Lu Yu, Lijuan Hu, Zongru Li, Ting Zhao, Wenbing Duan, Jing Wang, JinSong Jia, Jing Liu, Ya-Zhen Qin, Hao Jiang, Xiaohui Zhang, Feifei Tang, Yuqian Sun, XiaoDong Mo, LanPing Xu, Yu Wang, Xiaojun Huang, Qian Jiang

Blood (2024) 144 (Supplement 1): 1537.

https://doi.org/10.1182/blood-2024-207269

Published: 2024

Journal Articles

KPT-330 Combined with Radiation Therapy: Effective Central Nervous System Lymphoma Treatment with Reduced Neurotoxicity

Wenzhuo Zhuang, Yuchen Zhang, Chunxiao Yang, Linlin Qin, Ruijing Hu, Menglu Chen, Xinyuan Zhang, Qi Li, Xingping Lang, Si Chen, Bingzong Li

Blood (2024) 144 (Supplement 1): 958.

https://doi.org/10.1182/blood-2024-198290

Published: 2024

Journal Articles

Olverembatinib-Therapy in Patients with Accelerated-Phase Chronic Myeloid Leukaemia: A Multi-Centre Retrospective Study from China

Blood (2024) 144 (Supplement 1): 1767.

https://doi.org/10.1182/blood-2024-206453

Published: 2024

Journal Articles

A Multi-Center Clinical Trial of Allogeneic Hematopoietic Stem Cell Transplants in Transfusion Dependent Thalassemia

Blood (2024) 144 (Supplement 1): 378.

https://doi.org/10.1182/blood-2024-204984

Published: 2024

Journal Articles

A Novel Genome-Scale CRISPR-Cas12a Screen Identifies Ptpa As a Fetal Hemoglobin Regulator Via BCL11A

Elizabeth A. Traxler, Chad Komar, Megan Saari, Quynn Hotan, A Josephine Thrasher, Eugene Khandros, Kunhua Qin, Osheiza Abdulmalik, Claire Shao, Qingzhou Chen, Andy J. Minn, Cheryl A. Keller, Junwei Shi, Gerd A. Blobel

Blood (2024) 144 (Supplement 1): 412.

https://doi.org/10.1182/blood-2024-210117

Published: 2024

Journal Articles

HOPE-PMF: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Assess Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Early/Lower-Risk Primary Myelofibrosis

Ghaith Abu-Zeinah, Albert Qin, Harinder Gill, Norio Komatsu, John O. Mascarenhas, Weichung Joe Shih, Oleh Zagrijtschuk, Toshiaki Sato, Kazuya Shimoda, Richard T. Silver, Ruben A. Mesa

Blood (2024) 144 (Supplement 1): 3191.1.

https://doi.org/10.1182/blood-2024-200319

Published: 2024

Journal Articles

Exploration of the Specific Mechanism of EGR2 Hotspot Mutation Mediating the Upregulation of Galectin-1 Expression in the Progression of CLL Following Treatment with BTK Inhibitor

Xiao Lu, Yeqin Sha, Xinyu Song, Luomengjia Dai, Ziyuan Zhou, Hanning Tang, Yi Miao, Shuchao Qin, Yi Xia, Tonglu Qiu, Lei Fan, Jianyong Li, Huayuan Zhu

Blood (2024) 144 (Supplement 1): 4612.

https://doi.org/10.1182/blood-2024-207729

Published: 2024

Journal Articles

Molecular Biology Study of Primary Immuno-Privileged Lymphomas

Chen Zhang, Jili Deng, Lan Mi, Jiayue Qin, Lixia Liu, Yuqin Song

Blood (2024) 144 (Supplement 1): 4455.

https://doi.org/10.1182/blood-2024-212058

Published: 2024

Journal Articles

Preclinical Efficacy of Decoy-Resistant IL-18 in Hematological Malignancies

Jeffrey N Lindquist, Kai Qin, Jeffrey M Liu, Aaron M Ring, Hirdesh Uppal

Blood (2024) 144 (Supplement 1): 4965.

https://doi.org/10.1182/blood-2024-205690

Published: 2024

Journal Articles

Treatment Patterns of Ropeginterferon Alfa-2b-Njft in the Real-World Setting

Hung-Lun Chien, Craig Zimmerman, Andrew Howe, Robert Geller, Albert Qin

Blood (2024) 144 (Supplement 1): 5184.

https://doi.org/10.1182/blood-2024-206228

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Single-cell panleukemia signatures of HSPC-like blasts predict drug response and clinical outcome

Targeting caseinolytic mitochondrial matrix peptidase, a novel contributor to the pathobiology of high-risk multiple myeloma

N-homocysteinylation of β-arrestins biases GPCR signaling and promotes platelet activation

Targeting Enterobacter cloacae attenuates osteolysis by reducing ammonium in multiple myeloma

Venetoclax, Azacitidine, Combined with Low-Dose Cytarabine in Older Newly Diagnosed Acute Myeloid Leukemia：the Result of a Prospective, Multicenter, Open, Randomized Controlled Trials

A Prospective Clinical Study of Venetoclax Plus Azacitidine for the Maintenance Treatment of Post-Remission Acute Myeloid Leukemia

A Phase 1 Dose Escalation and Expansion Trial of Third-Generation CD19-Directed CAR T-Cells Incorporating CD28 and Toll-like Receptor 2 (TLR2) Co-Stimulation for Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas (ENABLE-1)

Elucidation of Molecular Mechanisms of Iberdomide and Mezigdomide Resistance in Cell Line Models of Multiple Myeloma

Single-Cell Multi-Omic Profiling of Patients with BCMA-Targeted Therapy Identifies Molecular and Cellular Factors Associated with Responsiveness and Treatment Effects

Factors Associated with Progression to Overt Acute Myeloid Leukemia in NPM1 -Mutated Myeloid Neoplasms with Less Than 10% Blasts

Genetic Abnormalities Associated with Outcomes in Unfit Patients with Acute Myeloid Leukemia Receiving Less Intensive Therapy in the Real World

KPT-330 Combined with Radiation Therapy: Effective Central Nervous System Lymphoma Treatment with Reduced Neurotoxicity

Olverembatinib-Therapy in Patients with Accelerated-Phase Chronic Myeloid Leukaemia: A Multi-Centre Retrospective Study from China

A Multi-Center Clinical Trial of Allogeneic Hematopoietic Stem Cell Transplants in Transfusion Dependent Thalassemia

A Novel Genome-Scale CRISPR-Cas12a Screen Identifies Ptpa As a Fetal Hemoglobin Regulator Via BCL11A

HOPE-PMF: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Assess Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Early/Lower-Risk Primary Myelofibrosis

Exploration of the Specific Mechanism of EGR2 Hotspot Mutation Mediating the Upregulation of Galectin-1 Expression in the Progression of CLL Following Treatment with BTK Inhibitor

Molecular Biology Study of Primary Immuno-Privileged Lymphomas

Preclinical Efficacy of Decoy-Resistant IL-18 in Hematological Malignancies

Treatment Patterns of Ropeginterferon Alfa-2b-Njft in the Real-World Setting

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only